On Monday, Shares of MannKind Corp. (NASDAQ:MNKD), gained 18.14% to $7.23.
MannKind Corporation, acknowledged that Executive Chairman Alfred Mann was honored last night at a gala for his extensive work in the progression and advancement of diabetes technologies and advocacy.
Held in conjunction with the 75th annual American Diabetes Association Scientific Sessions in Boston, the reception was co-hosted by Kelly L. Close, leading diabetes advocate and founder of the diaTribe Foundation, together with Dr. Steven Edelman, nationally recognized endocrinologist and founder of Take Control of Your Diabetes (TCOYD). In addition to last night’s honors, Mr. Mann was also recently awarded the JDRF’s Lifetime Achievement Award, one of the leading awards in diabetes internationally.
During the event, several diabetes patients expressed the personal impact that Mann’s biomedical advances have made in disease administration.
“Al Mann changed the lives of countless patients with diabetes,” said Ms. Close. “Without him, I might not be here recently. His introduction of the insulin pump, pioneering work in continuous glucose monitoring, and continued innovation with his most recent product, Afrezza, has solidified Mann’s lasting footprint on diabetes care.”
Mann devoted his career to fulfilling unmet patient needs in a range of areas, assisting those who were blind, deaf or suffering from complications of chronic diseases. “Diabetes or otherwise, it is doubtful many of today’s greatest medical technologies would ever have reached the market if not for Al’s tenacity and dedication. Al created an avalanche of technology,” added Dr. Steven Edelman.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States.
Shares of Rite Aid Corporation (NYSE:RAD), inclined 0.24% to $8.33, during its last trading session.
Rite Aid Corporation, declared sales results for May.
Monthly Sales
For the five weeks ended May 30, 2015, same store sales raised 2.1 percent over the preceding-year period. May front-end same store sales raised 0.1 percent. Pharmacy same store sales, which comprised of an approximate 179 basis points negative impact from new generic introductions, raised 3.0 percent. Prescription count at comparable stores raised 0.7 percent over the preceding-year period.
Total drugstore sales for the five-week period raised 2.0 percent to $2.535 billion contrast to $2.484 billion for the same period last year. Prescription sales accounted for 68.7 percent of drugstore sales, and third party prescription sales represented 97.8 percent of pharmacy sales.
Quarterly Sales
Same store sales for the 13-week period ended May 30, 2015 raised 2.9 percent over the preceding-year period. Front-end same store sales raised 0.6 percent while pharmacy same store sales raised 3.9 percent. Prescription count at comparable stores raised 1.6 percent over the preceding-year period.
Total drugstore sales for the 13 weeks ended May 30, 2015 raised 2.8 percent with sales of $6.603 billion contrast to $6.425 billion for the same period last year. Prescription sales represented 69.1 percent of total drugstore sales, and third party prescription sales represented 97.7 percent of pharmacy sales.
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
At the end of Monday’s trade, Shares of Groupon, Inc. (NASDAQ:GRPN), lost -1.81% to $5.98,
Groupon, declared it has named Rich Williams as Chief Operating Officer to oversee its global businesses and operations. Williams presently serves as President of North America and will continue in that capacity while adding responsibility for Groupon’s international regions.
“Rich has been integral in steering our North American local business to three successive quarters of double-digit growth and assisting to lead Groupon’s transformation to a mobile commerce marketplace,” said CEO Eric Lefkofsky. “As North America continues to be the leading edge of our tools, systems and processes, Rich is perfectly positioned to bring that operational leverage to our international markets.”
The leadership teams for EMEA, Rest of World and Global Operations will report to Williams, in addition to his current team.
Groupon, Inc. operates online local commerce marketplaces that connect merchants to consumers by offering goods and services at a discount worldwide. It also offers deals on products for which it acts as the merchant of record.
Finally, Melco Crown Entertainment Limited (NASDAQ:MPEL), ended its last trade with -4.56% decline, and closed at $19.99, following a note from analyst firm Sterne Agee that suggests gaming revenue in Macau is falling in June so far.
In a note to investors, Sterne Agee CRT analyst David Bain said, “According to our channel checks, Macau table-only gross gaming revenue (“GGR”) is MOP3.3 billion (USD$410m) from June 1 to June 7.” The June run rate suggests that GGR will fall 46% year over year in June to MOP14.6 billion ($1.8 billion).
Melco Crown Entertainment Limited, through its auxiliaries, develops, owns, and operates casino gaming and entertainment resort facilities in Asia. It owns and operates City of Dreams, an integrated casino resort that has 500 gaming tables and 1,400 gaming machines; about 1,400 hotel rooms and suites; a wet stage performance theater with about 2,000 seats; about 30 restaurants and bars, and 70 retail outlets; and recreation and leisure facilities, counting health and fitness clubs, swimming pools, spa and salons, and banquet and meeting facilities.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
